Clinical use of anti-TNF therapy and increased risk of infections

@inproceedings{Ali2013ClinicalUO,
  title={Clinical use of anti-TNF therapy and increased risk of infections},
  author={Tauseef Ali and Sindhu Kaitha and Sultan Mahmood and Abdul Ftesi and Jordan M. Stone and Michael S. Bronze},
  booktitle={Drug, healthcare and patient safety},
  year={2013}
}
Biologics such as antitumor necrosis factor (anti-TNF) drugs have emerged as important agents in the treatment of many chronic inflammatory diseases, especially in cases refractory to conventional treatment modalities. However, opportunistic infections have become a major safety concern in patients on anti-TNF therapy, and physicians who utilize these agents must understand the increased risks of infection. A literature review of the published data on the risk of bacterial, viral, fungal, and… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
28 Extracted Citations
177 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 28 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 177 references

Risk factors for opportunistic infections in patients with inflammatory bowel disease

  • M Toruner, EV JrLoftus, WS Harmsen
  • Gastroenterology
  • 2008
Highly Influential
4 Excerpts

Pneumocystis pneumonia

  • Thomas CF, AH Limper
  • New Engl J Med
  • 2004
Highly Influential
7 Excerpts

The burden of hepatitis C in the United States. Hepatology

  • WR Kim
  • Suppl 1):S30–S34
  • 2002
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…